$ZS

Zscaler expects more than $8B in organic ARR by FY31, but Morgan Stanley waits for client growth

Zscaler projected over $8B in organic ARR by FY2031 at its Investor Day. Morgan Stanley analysts await client growth before revising their stance.

Original reporting
Published Oct 7, 2026, 5:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 5:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ZSNeutralMed
01

Why it matters

The guidance could reshape analyst revenue models and influence valuation multiples for the company and its peers.

02

Market read

New guidance is a primary catalyst for Zscaler's stock, with potential spill‑over to the broader cybersecurity sector.

03

What to watch

Potential macro‑economic slowdown could curb enterprise IT spending, delaying client acquisition.

Relevance 8/10Novelty 8/10Timing: post‑Investor Day today

Background

Zscaler used its Investor Day to outline a long‑term revenue roadmap, emphasizing organic ARR growth beyond current levels.

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

Zscaler disclosed at its Investor Day a target of >$8 B organic ARR by FY2031, a new long‑term guidance figure not previously reported.

Expected impact

potential upside if growth materializes, but near‑term pressure as investors await evidence of client expansion.

Evidence & confidence

The $8 B ARR target is a material, forward‑looking metric for a mid‑cap security‑cloud firm; market reaction will depend on perceived feasibility.

Market effects

Sets a higher growth benchmark for the cloud‑security sector, may pressure peers to raise guidance.

U.S. tech market may see modest uplift in security‑software stocks.

Limited; primarily affects U.S. investors focused on cybersecurity exposure.

Counterpoint

The $8 B ARR goal may be overly optimistic given competitive pressures and client churn risk.

Key entities

  • Zscaler

    U.S. cloud‑security provider (ticker ZS).

  • Morgan Stanley

    Equity research firm expressing caution on client growth.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.

$ZSHigh

RBC Capital maintains Zscaler stock rating on $8B ARR target

RBC Capital reiterated an Outperform rating and $236.00 price target on Zscaler (ZS) after the company's Investor Day, where it set an $8B ARR target for 2031. The stock trades at $210.94, and analysts have raised earnings estimates. Several firms increased price targets, with Cantor Fitzgerald setting the highest at $275.